- Home
- ISPC
ISPC
iSpecimen Inc.
as 04-25-2025 4:00pm EST
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | WOBURN |
| Market Cap: | 3.1M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 141.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -17.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.02 - $11.80 | Next Earning Date: | 04-14-2025 |
| Revenue: | $9,291,115 | Revenue Growth: | -6.42% |
| Revenue Growth (this year): | 35.93% | Revenue Growth (next year): | N/A |
Latest iSpecimen Inc. News
ISPC Breaking Stock News: Dive into ISPC Ticker-Specific Updates for Smart Investing
Newsfile
3 months ago
iSpecimen Secures Suppliers for COVID-style hMPV Outbreak
Newsfile
4 months ago
iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens
Newsfile
4 months ago
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
Newsfile
4 months ago
iSpecimen Appoints Robert Lim as CEO and Director
Newsfile
6 months ago
iSpecimen Named Top Competitor in $4.4 Billion USD Market
GlobeNewswire
6 months ago
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually
GlobeNewswire
6 months ago
iSpecimen Reports Third Quarter 2024 Results
GlobeNewswire
6 months ago
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Compare ISPC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ISPC iSpecimen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.